Research and Development

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

Teva Pharmaceuticals vice chairman Professor Moshe Many has requested to leave the firm at the end of this month for …

Bristol-Myers Squibb has elected Thomas Lynch to its board to serve as a member on its Science and Technology Committee …

The year 2013 brought a new series of challenges for pharma. As the dust settled following the bulk of major …

Comms giant McCann Health has hired Susan Duffy to be president of its New York-based McCann Regan Campbell Ward (RCW). …

AstraZeneca has pledged to donate its Devon-based Environmental Laboratory to Plymouth University, after announcing the site’s closure in October. The …

The ABPI has appointed Raj Tugnet as its new NHS partnership manager to lead ABPI activities on academic health science …

UK prime minister David Cameron has announced that the government is to increase funding research into dementia, spending £52 million …

AbbVie’s investigational hepatitis C pill cured 96% of difficult-to-treat patients in a late-stage clinical trial and looks set to muscle …

Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …

Johnson & Johnson has chosen the UK as its formal European hub after announcing the creation of five new sites …

Small molecule lead discovery firm Nuevolution has poached Ton Berkien from Takeda to join the firm as a chief business …

AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …

The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …

Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …